Human phase-1 Multiple Ascending Dose (MAD) study - safety, tolerability and pharmacokinetics of SUVN-502, a 5-HT6 receptor antagonist

✍ Scribed by Ramakrishna Nirogi; Vishwottam Kandikere; Koteshwara Mudigonda; Gopinadh Bhyrapuneni; Venkat Jasti

• Book ID: 118464890
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 55 KB
• Volume: 5
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2009.04.261